Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiola Atzeni

Showing results (341-350 of 395) with videos related to

Pageof 40
Sort By:
Rheumatology (Oxford, England)|June 5, 2025
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort studyMaryam A Adas, Katie Bechman, Mark D Russell, et al.
Clinical and Experimental Rheumatology|September 6, 2022
The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmodFausto Salaffi, Marco Di Carlo, Sonia Farah, et al.
European Journal of Internal Medicine|May 26, 2026
Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR databaseBlaž Burja, Marouane Boubaya, Cosimo Bruni, et al.
Clinical Rheumatology|October 12, 2021
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational studyPiero Ruscitti, Ilenia Di Cola, Onorina Berardicurti, et al.
Clinical and Experimental Rheumatology|April 3, 2026
Interstitial lung involvement in rheumatoid arthritis patients treated with abatacept: a prospective observational studyCaterina Vacchi, Marco Sebastiani, Antonio Carletto, et al.
Clinical and Experimental Rheumatology|December 18, 2020
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational studyPiero Ruscitti, Paola Cipriani, Vasiliki Liakouli, et al.
Frontiers in Pharmacology|May 15, 2026
Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritisRoberta Ramonda, Mariagrazia Lorenzin, Antonio Carletto, et al.
Arthritis Research & Therapy|September 5, 2019
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) studyPiero Ruscitti, Paola Cipriani, Vasiliki Liakouli, et al.
European Journal of Pain (London, England)|September 26, 2024
Geographical disparities in fibromyalgia severity: An Italian studyMarco Di Carlo, Sonia Farah, Fabiola Atzeni, et al.
Frontiers in Immunology|July 30, 2024
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritisRoberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Pageof 40

Showing results (341-350 of 395) with videos related to

Sort By:
Pageof 40
Rheumatology (Oxford, England)|June 5, 2025
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort studyMaryam A Adas, Katie Bechman, Mark D Russell, et al.
Clinical and Experimental Rheumatology|September 6, 2022
The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmodFausto Salaffi, Marco Di Carlo, Sonia Farah, et al.
European Journal of Internal Medicine|May 26, 2026
Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR databaseBlaž Burja, Marouane Boubaya, Cosimo Bruni, et al.
Clinical Rheumatology|October 12, 2021
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational studyPiero Ruscitti, Ilenia Di Cola, Onorina Berardicurti, et al.
Clinical and Experimental Rheumatology|April 3, 2026
Interstitial lung involvement in rheumatoid arthritis patients treated with abatacept: a prospective observational studyCaterina Vacchi, Marco Sebastiani, Antonio Carletto, et al.
Clinical and Experimental Rheumatology|December 18, 2020
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational studyPiero Ruscitti, Paola Cipriani, Vasiliki Liakouli, et al.
Frontiers in Pharmacology|May 15, 2026
Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritisRoberta Ramonda, Mariagrazia Lorenzin, Antonio Carletto, et al.
Arthritis Research & Therapy|September 5, 2019
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) studyPiero Ruscitti, Paola Cipriani, Vasiliki Liakouli, et al.
European Journal of Pain (London, England)|September 26, 2024
Geographical disparities in fibromyalgia severity: An Italian studyMarco Di Carlo, Sonia Farah, Fabiola Atzeni, et al.
Frontiers in Immunology|July 30, 2024
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritisRoberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Pageof 40